ARCS Annual Conference 2026
The conference will focus on the latest regulatory updates from the Therapeutic Goods Administration (TGA), advancements in clinical trial methodologies, and emerging challenges and trends affecting the sector. Moreover, this event serves as a critical forum for discussing the future direction of the pharmaceutical and medtech industries in Australia. Participants will contribute to discussions on policy developments, innovation pathways, and strategies to enhance patient outcomes and industry growth.
Date: June 10-12, 2026
Location: Sydney, Australia
Booth: # 83
JOIN US!
Join us for the 2026 ARCS Annual Conference in Sydney, Australia, more leaders gather for practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, come meet our APAC team during this event to learn about our flexible, comprehensive clinical supply services and how we can help support your studies.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS
Date/Time: 12 June, 12:45–1:15pm.
Title: 2026 ARCS Annual Conference Educational Session
Content: Key to clinical supply and how to fasten your trials from Australia to Global Tracey Clare, Head of Commercial & Operations, APAC
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.
